Compare SUVEN LIFE with JUBILANT LIFE SCIENCES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs JUBILANT LIFE SCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES JUBILANT LIFE SCIENCES SUVEN LIFESCIENCES/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 21.5 13.0 165.1% View Chart
P/BV x 4.4 1.6 267.6% View Chart
Dividend Yield % 0.5 0.9 52.9%  

Financials

 SUVEN LIFESCIENCES   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
JUBILANT LIFE SCIENCES
Mar-19
SUVEN LIFESCIENCES/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs338898 37.6%   
Low Rs169618 27.4%   
Sales per share (Unadj.) Rs52.1572.0 9.1%  
Earnings per share (Unadj.) Rs6.836.2 18.9%  
Cash flow per share (Unadj.) Rs8.659.5 14.4%  
Dividends per share (Unadj.) Rs1.504.50 33.3%  
Dividend yield (eoy) %0.60.6 99.6%  
Book value per share (Unadj.) Rs65.3301.9 21.6%  
Shares outstanding (eoy) m127.28159.28 79.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.91.3 367.2%   
Avg P/E ratio x37.120.9 177.5%  
P/CF ratio (eoy) x29.612.7 232.4%  
Price / Book Value ratio x3.92.5 154.7%  
Dividend payout %22.012.4 176.8%   
Avg Mkt Cap Rs m32,272120,694 26.7%   
No. of employees `0001.12.4 45.3%   
Total wages/salary Rs m66119,260 3.4%   
Avg. sales/employee Rs Th6,132.238,120.6 16.1%   
Avg. wages/employee Rs Th611.18,058.4 7.6%   
Avg. net profit/employee Rs Th803.52,414.3 33.3%   
INCOME DATA
Net Sales Rs m6,63591,108 7.3%  
Other income Rs m242357 67.8%   
Total revenues Rs m6,87791,466 7.5%   
Gross profit Rs m1,60417,390 9.2%  
Depreciation Rs m2213,709 6.0%   
Interest Rs m382,198 1.7%   
Profit before tax Rs m1,58711,840 13.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-2,802 0.0%   
Tax Rs m7183,268 22.0%   
Profit after tax Rs m8695,770 15.1%  
Gross profit margin %24.219.1 126.7%  
Effective tax rate %45.227.6 163.9%   
Net profit margin %13.16.3 206.9%  
BALANCE SHEET DATA
Current assets Rs m6,23245,848 13.6%   
Current liabilities Rs m1,49020,897 7.1%   
Net working cap to sales %71.527.4 261.0%  
Current ratio x4.22.2 190.6%  
Inventory Days Days8657 152.2%  
Debtors Days Days8351 162.1%  
Net fixed assets Rs m4,04365,498 6.2%   
Share capital Rs m127159 79.9%   
"Free" reserves Rs m8,18347,930 17.1%   
Net worth Rs m8,31048,089 17.3%   
Long term debt Rs m1842,429 0.0%   
Total assets Rs m10,389114,685 9.1%  
Interest coverage x43.16.4 674.9%   
Debt to equity ratio x00.9 0.2%  
Sales to assets ratio x0.60.8 80.4%   
Return on assets %8.76.9 125.7%  
Return on equity %10.512.0 87.2%  
Return on capital %19.512.4 157.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,62212,422 45.3%   
Fx outflow Rs m1,79917,227 10.4%   
Net fx Rs m3,822-4,805 -79.5%   
CASH FLOW
From Operations Rs m35611,215 3.2%  
From Investments Rs m-279-10,118 2.8%  
From Financial Activity Rs m-2256,574 -3.4%  
Net Cashflow Rs m-1487,612 -1.9%  

Share Holding

Indian Promoters % 63.4 45.6 139.0%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 0.0 8.7 -  
FIIs % 0.0 21.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 21.1 173.0%  
Shareholders   37,287 23,815 156.6%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   ALEMBIC LTD  SHASUN PHARMA  PFIZER  FDC LTD.  ORCHID PHARMA LTD  

Compare SUVEN LIFESCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 70 Points Higher; Telecom and Banking Stocks Advance(Closing)

Indian share markets traded on a positive note throughout the day and ended marginally higher. The BSE Sensex rose over 350 points intraday.

Related Views on News

SUVEN LIFESCIENCES at 52 Week High; BSE 500 Index Up 1.0% (Market Updates)

Nov 15, 2019 | Updated on Nov 15, 2019

SUVEN LIFESCIENCES share price has hit a 52-week high. It is presently trading at Rs 333. BSE 500 Index is up by 0.5% at 15,394. Within the BSE 500, SUVEN LIFESCIENCES (up 3.6%) and CORPORATION BANK (up 9.2%) are among the top gainers, while top losers are VODAFONE IDEA and SUZLON ENERGY.

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY20); Net Profit Up 18.9% (Quarterly Result Update)

Oct 31, 2019 | Updated on Oct 31, 2019

For the quarter ended September 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 18.9% YoY). Sales on the other hand came in at Rs 23 bn (down 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Nov 15, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES - PROCTER & GAMBLE HEALTH COMPARISON

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS